What the Hell Happened to My Executive Function?

Adult ADHD diagnoses are growing four times faster than childhood diagnoses. Among adults over thirty, new diagnosis rates have risen more than sixty percent since 2021. ADHD diagnoses among women nearly doubled in just two years, from 2020 to 2022. In 2022, women surpassed men in total stimulant prescriptions dispensed for the first time. Sixty-one percent of women with ADHD received their diagnosis in adulthood, compared to forty percent of men.

Something is clearly happening. But what, exactly, is it?

A large portion of this surge represents genuine recognition. ADHD doesn't only belong to hyperactive ten-year-old boys, and the fact that clinicians are finally diagnosing it across gender and age is a correction that was decades overdue. For many of these people, the diagnosis is accurate. The relief is real. The treatment is appropriate.

But something doesn't add up.

The fastest-growing segment isn't twenty-somethings finally making sense of a chaotic adolescence. It's high-achieving adults in midlife. People in their forties and fifties who run companies, manage complex lives, and have trusted their brains to deliver for twenty or thirty years. For these people, the refrain isn't "I've always been like this." It's "something changed."

You're in a meeting you organized and lose the thread of your own point. You open your laptop to do something specific and fifteen minutes later realize you haven't started. You read the same paragraph three times and it won't stick. These aren't things that happened to you before. That's the part that's hard to explain. You read an article about adult ADHD, took an online screener, and thought: That's it. That's what this is.

And maybe it is. But for a meaningful subset of this population, I think it isn't. Which is important, because it changes everything about what to do next.

The Diagnosis That May Not Be a Diagnosis

The clinical system, to its credit, is finally recognizing that ADHD persists across the lifespan and presents differently in women than in men. The diagnosis is real. The symptoms are real. And for many adults, the relief of finally having a name for what they've always experienced is profound.

But embedded within this surge is a different population, one whose symptoms are equally real, equally disruptive, and almost completely misunderstood.

These are people who don't have ADHD in the neurodevelopmental sense. They have something that looks identical from the outside, and from the inside, for that matter. But it emerges from an entirely different set of causes. And because the two are clinically indistinguishable by current standard-of-care diagnosis, they're being treated the same way: with stimulants that address the symptom while leaving the underlying mechanism untouched.

The stimulants often help, at least initially. Which reinforces the assumption that the diagnosis was correct. Which means the conversation about the underlying cause never takes place.

The Filter Problem

Here is a useful way to think about the distinction.

Neurodevelopmental ADHD (nADHD) is the condition that begins in childhood and persists across the lifespan. For those with nADHD, the brain's executive filters were never fully constructed. The prefrontal architecture that governs attention, impulse control, and working memory was laid down differently from the start. These individuals didn't develop a problem in midlife. They have always had this brain. What changes in midlife for this "had it since childhood" population is that the coping strategies they built over decades (often unconsciously, often heroically) begin to buckle under accumulating demands. The diagnosis feels like recognition. I was never broken. This is just how my brain works.

The second population, the one this essay is about, is different. Their filters were built. Built well, in fact. The evidence is the twenty or thirty years of high-level function that preceded the decline. These are people whose cognitive architecture performed reliably. Not effortlessly, of course. But without the constant compensatory work that masks undiagnosed ADHD. What happened to them is different: the installed filters are being eroded.

The erosion is biological. And it follows a specific, traceable, surprisingly coherent pattern.

What's Driving It

The brain's ability to direct and sustain attention depends heavily on dopamine, specifically on the density and sensitivity of dopamine receptors in the prefrontal cortex. When those receptors are functioning well, the system works. When they're compromised, it doesn't. The experience is subjectively indistinguishable from ADHD, even though the cause is completely different.

What compromises the system is chronic cortisol.

Not the acute kind. Not a crisis, not a deadline, not a quarter that nearly went sideways. You're built for those. The kind that accumulates is subtler: fifteen years of decisions where the stakes are real but the feedback is delayed or absent. The deal that closes but immediately becomes the next deal. The quarter that went well, which means expectations just went up. A calendar that never has a week where everything is handled. Your brain keeps modeling future threats because nothing ever arrives at done. It was never designed to run that way indefinitely.

In the model I'm describing, sustained cortisol does two things to the dopamine system simultaneously. It suppresses the synthesis of dopamine (less of it gets made). And it drives the internalization of dopamine receptors (fewer of them are available on the cell surface). The prefrontal cortex, which is highly sensitive to dopamine levels, begins to degrade. Attention becomes unstable. Working memory shrinks. Initiation, that mysterious yet essential first gear, becomes unreliable.

This is not aging. Or rather, it is aging in the sense that it tends to emerge in midlife. But it is not the inevitable cognitive decline of getting older. It is a specific, mechanistically coherent failure cascade that happens to produce a presentation virtually identical to ADHD.

Layered on top of this is chronic low-grade inflammation, what researchers call "inflammaging." The chronic inflammation further impairs neuroplasticity, disrupts neurotransmitter production, and creates a kind of biological rigidity that makes the system resistant to the ordinary interventions that might otherwise help. Therapy addresses the thoughts but not the biology. SSRIs address serotonin but not the dopamine suppression or the prediction loop driving it. Exercise helps, but less than it should, because the inflammatory state blunts the response. And stimulants, which force dopamine availability regardless of the underlying cause, address the output of the system while leaving the mechanism running.

For women, there is an additional layer.

Estrogen is not just a reproductive hormone. It modulates dopamine receptor density and synthesis in the prefrontal cortex through many of the same pathways that cortisol degrades. The two systems are, in effect, pulling on opposite ends of the same rope. For decades, estrogen has been quietly offsetting some of the dopamine suppression that chronic cortisol was producing. Then, in perimenopause, estrogen withdrawal removes that offset. What was a slow erosion becomes a sudden drop. The inflection point arrives faster, hits harder, and is far more likely to be attributed to "hormones" or "perimenopause" than to the underlying cascade that was already running.

This is why the surge in midlife ADHD diagnoses is disproportionately female. And why it is being misread. The hormonal withdrawal is real. But in many of these women, it is the precipitant that made a pre-existing constraint failure visible, not the cause of a lifelong neurodevelopmental condition that somehow went unnoticed for forty years.

How to Tell the Difference

The most significant differentiator is history. Not symptoms. History.

Neurodevelopmental ADHD tends to produce retrospective recognition. When people with undiagnosed nADHD finally encounter the framework, they look back at their entire life and see it differently. The struggles in school that were attributed to laziness or attitude. The relationships that frayed because of impulsivity. The jobs that went sideways because of chronic disorganization. The diagnosis doesn't explain something new. It reframes everything old.

The people I'm describing here have a different story. Their retrospective is one of competence. They were organized. They were reliable. They were, often, the person others depended on to hold things together. When they look back, they don't find a lifetime of hidden struggle. They find a peak... and then an inflection point. A specific period, often identifiable within a year or two, when something changed.

The inflection point usually coincides with a life-stage transition. Children leaving. A major role change. A health event. The removal of the external structures like deadlines, accountability, or the sheer forward momentum of building something that had, without their awareness, been providing the cognitive architecture their brain needed to perform. When those external constraints lifted, the internal machinery, already running on diminished dopamine reserves, had nothing left to organize itself around.

The other differentiators are more biological: patterns in sleep; in how the body responds to stimulants if they've been tried; in measurable markers of autonomic flexibility and inflammatory burden. But the historical narrative is often sufficient to orient the conversation.

When a brilliant, accomplished fifty-two-year-old says I think I might have ADHD, the most important question is not "what are your symptoms?" It is: "Did you always feel this way, or did something change?"

And for women, when the inflection point coincides with perimenopause (as it frequently does) the hormonal explanation feels complete. Of course something changed. My estrogen dropped. And that explanation isn't wrong. But it may be insufficient. The more useful question is whether hormone therapy, if tried, restored baseline function. If it did, the hormonal withdrawal was likely the primary driver. If it helped but didn't restore baseline (you're still not quite yourself even with hormones stabilized), the cascade was probably already running underneath, and the hormonal shift was the event that made it impossible to compensate around any longer.

What This Framework Doesn't Yet Have

This is a hypothesis, not a settled diagnosis. The mechanisms I've described (chronic cortisol suppressing dopamine, inflammaging compounding the damage, hormonal withdrawal accelerating the timeline) are individually grounded in research, but the convergent pattern has not been validated in a clinical trial. The biological differentiators I mentioned earlier may eventually help clinicians make the distinction more precisely, but that work awaits the study that would confirm or refute it. Someone should design that study. The population is identifiable, the biomarkers are measurable, and the clinical implications would be significant.

Cognitive symptoms in midlife have many possible causes: disrupted sleep, depression, thyroid dysfunction, vascular changes. Every one of them deserves proper clinical evaluation before any framework gets applied. This essay is not a reason to skip that step. It's a reason to ask better questions once you've taken it.

The Question To Ask

If you run things, built things, trusted your brain to deliver, and have watched that reliability degrade, then the most useful thing I can leave you with is a single question:

Was this always true, or did something change?

If the answer is always: If a diagnosis of ADHD reframes not just the last few years but your entire life, then you're likely looking at a neurodevelopmental condition, finally identified. That path runs through qualified psychiatric care, and it's increasingly well-supported. The fact that the system missed it for decades is a failure now being corrected. Take the diagnosis seriously.

If the answer is something changed: If what you're describing is an eroding peak, not a lifelong struggle, then you're looking at a different problem entirely. Not a condition to be managed, but a cascade to be interrupted. The filters weren't absent. They were damaged. And restoring them means working at the level of the mechanism itself: the cortisol load that is suppressing your dopamine system, the inflammatory state that has made it rigid, and the prediction loop your brain can't stop running because nothing in your environment ever arrives at done.

Stimulants don't do this. Talk therapy doesn't do this. It requires a different class of intervention. One that works at the biological level while simultaneously addressing the cognitive and behavioral patterns that keep the cascade going.

The emerging research points toward interventions that work further upstream: lowering the inflammatory and autonomic stress load that has been throttling the dopamine system, so it can recover on its own. This works best when paired with structured changes to the routines that keep the cortisol load in place.

Both answers have paths forward. But they are not the same path.

References

Chung, Winston, Sheng-Fang Jiang, Diana Paksarian, et al. 2019. “Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.” JAMA Network Open2 (11): e1914344. 

Epic Research. 2023. “Number of ADHD Patients Rising, Especially Among Women.” March 30, 2023.

Staley, Brooke S., Lara R. Robinson, Angelika H. Claussen, et al. 2024. “Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults - National Center for Health Statistics Rapid Surveys System, United States, October-November 2023.” MMWR. Morbidity and Mortality Weekly Report 73 (40): 890–95. 

U.S. Drug Enforcement Administration, Diversion Control Division; IQVIA. (2024). Stimulant Prescription Trends in the United States from 2012–2023. November 13, 2024. 

Yuen, E. (2025). "ADHD in Adults: A Psychiatrist Explains." Yale Medicine. (Citing Truveta EHR analysis: first-time diagnosis rates, January 2021–October 2024.) 

Essays on treatment resistance, altered states, and the conditions under which change becomes possible.

Subscribe